# Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia

> **NCT00001623** · NA · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 41 (actual)

## Conditions studied

- Graft vs Host Disease
- Hematologic Neoplasm
- Leukemia
- Multiple Myeloma
- Myelodysplastic Syndrome

## Interventions

- **PROCEDURE:** Allogeneic Bone Marrow Transplant

## Key facts

- **NCT ID:** NCT00001623
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-03-27
- **Primary completion:** 2008-01-31
- **Final completion:** 2017-08-03
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001623, "Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00001623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*